StockWatch
·
Pharmaceuticals
Open Offer18 Jun 2026, 05:20 pm

Colinz Laboratories: Open Offer for 26% Stake at ₹54/Share

AI Summary

Saffron Capital Advisors Private Limited, acting as the Manager to the Offer, has announced a public open offer for Colinz Laboratories Limited. The offer aims to acquire up to 6,54,966 equity shares, representing 26% of the voting share capital, at a price of ₹54 per share. The total value of the open offer is ₹3,53,68,164. This move is in compliance with SEBI (SAST) Regulations, 2011, and involves Acquirers (Anjana Dugar, Likhitta Dugar, Antariksh Dugar) and a Person Acting in Concert (Padam Dugar), acquiring shares from a Seller (Vijaya Mani). The acquisition is based on a Share Purchase Agreement dated June 18, 2026.

Key Highlights

  • Open offer to acquire 26% of Colinz Laboratories' voting share capital.
  • Offer price set at ₹54 per equity share.
  • Total offer value amounts to ₹3,53,68,164.
  • Acquisition is compliant with SEBI (SAST) Regulations, 2011.
  • Involves multiple acquirers and a person acting in concert.